Endocrine tumours (Q65506): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1909613405 / rank | |||
Normal rank | |||
Revision as of 13:13, 14 August 2026
Endocrine tumours, also referred to as neuroendocrine tumours (NETs), are defined by a common phenotype which is characterised by the expression of general markers (neuron specific enolase, chromogranin, synaptophysin) and hormone secretion products. These tumours may be localised in any part of the body and the most common localisations are the lungs, ileus, appendix, or rectum. Neuroectodermal NETs include medullary thyroid cancer, pheochromocytoma, and paraganglioma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1909613405 |
||
| English | Endocrine tumours |
Endocrine tumours, also referred to as neuroendocrine tumours (NETs), are defined by a common phenotype which is characterised by the expression of general markers (neuron specific enolase, chromogranin, synaptophysin) and hormone secretion products. These tumours may be localised in any part of the body and the most common localisations are the lungs, ileus, appendix, or rectum. Neuroectodermal NETs include medullary thyroid cancer, pheochromocytoma, and paraganglioma. |
